Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)
| 58.36 Delayed Data As of Aug 03 |  +23.70 / +68.38%Today’s Change | 24.87 Today|||52-Week Range 129.71 | +34.53% Year-to-Date |
Latest ARCT News | Press Releases
| Why Arcturus Therapeutics Stock Is Soaring Today Aug 03 / MotleyFool.com - Paid Partner Content | Can Last Year's Biggest Vaccine Stocks Crush the Market Again? Aug 02 / MotleyFool.com - Paid Partner Content |
| Earnings Preview: Arcturus Therapeutics (ARCT) Q2 Earnings Expected to Decline Aug 02 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 34.66 |
| Today’s open | 39.38 |
| Day’s range | 39.38 - 60.33 |
| Volume | 202,940 |
| Average volume (3 months) | 619,204 |
| Market cap | $821.7M |
Data as of 5:03pm ET, 08/03/2021
Growth & Valuation
| Earnings growth (last year) | -65.00% |
| Earnings growth (this year) | -77.20% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -54.12% |
| P/E ratio | NM |
| Price/Sales | 92.34 |
| Price/Book | 2.06 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EPIXESSA Pharma Inc | -0.72 | -3.19% |
| ZGNXZogenix Inc | -0.02 | -0.12% |
| ACRSAclaris Therapeutics... | -0.17 | -1.13% |
| OMEROmeros Corp | -0.19 | -1.27% |
Data as of 4:00pm ET, 08/03/2021
Financials
| Next reporting date | August 10, 2021 |
| EPS forecast (this quarter) | -$2.22 |
| Annual revenue (last year) | $9.5M |
| Annual profit (last year) | -$72.1M |
| Net profit margin | -756.35% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
